Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Ni Jing(Selective Translation), Gong Zhenyu(Review)

Ni Jing; Gong Zhenyu

doi:10.3784/jbjc.202411070629

Ni Jing, Gong Zhenyu. Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Ni Jing(Selective Translation), Gong Zhenyu(Review)[J]. Disease Surveillance, 2025, 40(8): 1103-1105. DOI: 10.3784/jbjc.202411070629

Citation:

Ni Jing, Gong Zhenyu. Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Ni Jing(Selective Translation), Gong Zhenyu(Review)[J]. Disease Surveillance, 2025, 40(8): 1103-1105. DOI: 10.3784/jbjc.202411070629

Citation:

Ni Jing, Gong Zhenyu. Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Ni Jing(Selective Translation), Gong Zhenyu(Review)[J]. Disease Surveillance, 2025, 40(8): 1103-1105. DOI: 10.3784/jbjc.202411070629

Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Ni Jing(Selective Translation), Gong Zhenyu(Review)

Graphical Abstract

Graphical Abstract

Abstract

FullText(HTML)

References (0)

Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Ni Jing(Selective Translation), Gong Zhenyu(Review)

Graphical Abstract

Catalog

Export File

Citation

Format

Content